Device
Liposomes
Liposomes is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Phase Distribution
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completed
ex Vivo Study of Liposomes Loaded With Everolimus in Chronic Lung Allograft Disfunction
NCT07234760
completednot_applicable
Intravesical Liposomes for Ulcerative Cystitis
NCT01083979
completednot_applicable
Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)
NCT01731470
Clinical Trials (3)
Showing 3 of 3 trials
NCT07234760
ex Vivo Study of Liposomes Loaded With Everolimus in Chronic Lung Allograft Disfunction
NCT01083979Not Applicable
Intravesical Liposomes for Ulcerative Cystitis
NCT01731470Not Applicable
Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3